Kimberly Taylor, PhD (Q49706): Difference between revisions
From geokb
(Changed an Item: Updated official website (Staff Profile) claim with current qualifiers) |
(Changed an Item: removed references on instance of claim) |
||||||||||||||
(4 intermediate revisions by the same user not shown) | |||||||||||||||
description / en | description / en | ||||||||||||||
Program Officer | Program Officer with the California Water Science Center | ||||||||||||||
Property / instance of: person / reference | |||||||||||||||
Property / email address: mailto:ktaylor@usgs.gov / qualifier | |||||||||||||||
point in time: 12 May 2024
| |||||||||||||||
Property / email address: mailto:ktaylor@usgs.gov / qualifier | |||||||||||||||
| |||||||||||||||
Property / ORCID iD: 0000-0002-0095-6403 / qualifier | |||||||||||||||
status code: 200 | |||||||||||||||
Property / ORCID iD: 0000-0002-0095-6403 / qualifier | |||||||||||||||
last update: 23 May 2024
| |||||||||||||||
Property / ORCID iD: 0000-0002-0095-6403 / qualifier | |||||||||||||||
retrieved: 23 May 2024
| |||||||||||||||
Property / employer: United States Geological Survey / qualifier | |||||||||||||||
point in time: 12 May 2024
| |||||||||||||||
Property / employer: United States Geological Survey / qualifier | |||||||||||||||
| |||||||||||||||
Property / is affiliated with: California Water Science Center / qualifier | |||||||||||||||
point in time: 12 May 2024
| |||||||||||||||
Property / is affiliated with: California Water Science Center / qualifier | |||||||||||||||
| |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Renal Cell Carcinoma / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Renal Cell Carcinoma / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Renal Cell Carcinoma / qualifier | |||||||||||||||
prevalence: 5
| |||||||||||||||
Property / knows about: Renal Cell Carcinoma / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Management and Outcomes of Acute Kidney Injury / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Management and Outcomes of Acute Kidney Injury / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Management and Outcomes of Acute Kidney Injury / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: Management and Outcomes of Acute Kidney Injury / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Kidney Transplantation / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Kidney Transplantation / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Kidney Transplantation / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: Kidney Transplantation / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: Health Economics and Quality of Life Assessment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Perioperative Cardiac Risk Assessment and Management / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Perioperative Cardiac Risk Assessment and Management / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Perioperative Cardiac Risk Assessment and Management / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: Perioperative Cardiac Risk Assessment and Management / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Fluid Resuscitation in Trauma and Critical Care / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Fluid Resuscitation in Trauma and Critical Care / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Fluid Resuscitation in Trauma and Critical Care / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Fluid Resuscitation in Trauma and Critical Care / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Obstetric Vesicovaginal Fistula and Ureteral Injuries / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Obstetric Vesicovaginal Fistula and Ureteral Injuries / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Obstetric Vesicovaginal Fistula and Ureteral Injuries / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Obstetric Vesicovaginal Fistula and Ureteral Injuries / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Pheochromocytoma and Paraganglioma / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Pheochromocytoma and Paraganglioma / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Pheochromocytoma and Paraganglioma / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Pheochromocytoma and Paraganglioma / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Hematopoietic Stem Cell Biology / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Hematopoietic Stem Cell Biology / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Hematopoietic Stem Cell Biology / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Hematopoietic Stem Cell Biology / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Impact of Parental Illness on Children and Families / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Impact of Parental Illness on Children and Families / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Impact of Parental Illness on Children and Families / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Impact of Parental Illness on Children and Families / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Diagnosis and Treatment of Bladder Cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Diagnosis and Treatment of Bladder Cancer / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Diagnosis and Treatment of Bladder Cancer / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Diagnosis and Treatment of Bladder Cancer / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Prostate Cancer Research and Treatment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Prostate Cancer Research and Treatment / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Prostate Cancer Research and Treatment / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Prostate Cancer Research and Treatment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Factors Affecting Vaccine Hesitancy and Acceptance / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Factors Affecting Vaccine Hesitancy and Acceptance / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Factors Affecting Vaccine Hesitancy and Acceptance / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Factors Affecting Vaccine Hesitancy and Acceptance / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Diagnostic Approach to Fever of Unknown Origin / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Diagnostic Approach to Fever of Unknown Origin / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Diagnostic Approach to Fever of Unknown Origin / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Diagnostic Approach to Fever of Unknown Origin / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Advancements in Prostate Cancer Research / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Advancements in Prostate Cancer Research / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Advancements in Prostate Cancer Research / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Advancements in Prostate Cancer Research / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Positron Emission Tomography Imaging in Oncology / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Positron Emission Tomography Imaging in Oncology / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Positron Emission Tomography Imaging in Oncology / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Positron Emission Tomography Imaging in Oncology / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Eminent Domain and Property Rights / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Eminent Domain and Property Rights / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Eminent Domain and Property Rights / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Eminent Domain and Property Rights / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Integrated Pollution Prevention and Control Techniques / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Integrated Pollution Prevention and Control Techniques / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Integrated Pollution Prevention and Control Techniques / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Integrated Pollution Prevention and Control Techniques / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Psychological Effects of Perfectionism / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Psychological Effects of Perfectionism / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Psychological Effects of Perfectionism / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Psychological Effects of Perfectionism / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Global Trends in Industry Self-Regulation and Compliance / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Global Trends in Industry Self-Regulation and Compliance / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Global Trends in Industry Self-Regulation and Compliance / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Global Trends in Industry Self-Regulation and Compliance / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Impact of COVID-19 Infection on Pregnancy Outcomes / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Impact of COVID-19 Infection on Pregnancy Outcomes / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Impact of COVID-19 Infection on Pregnancy Outcomes / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Impact of COVID-19 Infection on Pregnancy Outcomes / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Obesity's Impact on Skin Physiology and Disorders / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Obesity's Impact on Skin Physiology and Disorders / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Obesity's Impact on Skin Physiology and Disorders / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Obesity's Impact on Skin Physiology and Disorders / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Economic Burden of Cancer Treatment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Economic Burden of Cancer Treatment / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Economic Burden of Cancer Treatment / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Economic Burden of Cancer Treatment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Abdominal Compartment Syndrome and Intra-abdominal Hypertension / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Abdominal Compartment Syndrome and Intra-abdominal Hypertension / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / knows about: Abdominal Compartment Syndrome and Intra-abdominal Hypertension / qualifier | |||||||||||||||
prevalence: 1
| |||||||||||||||
Property / knows about: Abdominal Compartment Syndrome and Intra-abdominal Hypertension / reference | |||||||||||||||
Property / OpenAlex ID | |||||||||||||||
Property / OpenAlex ID: A5010102498 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / OpenAlex ID: A5010102498 / qualifier | |||||||||||||||
last update: 23 August 2024
| |||||||||||||||
Property / OpenAlex ID: A5010102498 / qualifier | |||||||||||||||
retrieved: 29 August 2024
|
Revision as of 22:46, 6 September 2024
Program Officer with the California Water Science Center
Language | Label | Description | Also known as |
---|---|---|---|
English | Kimberly Taylor, PhD |
Program Officer with the California Water Science Center |
Statements
12 May 2024
12 May 2024
30 September 2023
12 May 2024
0 references
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference
23 August 2024
1 reference